Pfizer Inc.
PFE
Κατάταξη σε μετοχές
#118
Pfizer Inc. is a global biopharmaceutical leader engaged in the research,... Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.
Τιμή μετοχής
$29.47
Τελευταίος συγχρονισμός: 2026-10-19
Κεφαλαιοποίηση
$167.94B
Αλλαγή (1 ημέρα)
-0.27%
Αλλαγή (1 έτος)
19.34%
Χώρα
US
Εμπόριο Pfizer Inc. (PFE)
Κατηγορία
Healthcare
Κέρδη για την Pfizer Inc. (PFE)
Κέρδη τον Jun 2026 TTM: $4.21B
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της Pfizer Inc., τα τρέχοντα κέρδη της εταιρείας είναι $4.21B. Το 2024, η εταιρεία παρουσίασε κέρδη $8.02B, αύξηση σε σχέση με των κερδών του 2023 που ήταν $1.06B. Τα κέρδη που εμφανίζονται σε αυτή τη σελίδα είναι πριν από τόκους και φόρους, γνωστά και ως EBIT.
Ιστορικό κερδών για την Pfizer Inc. από 2000 έως 2026
Κέρδη στο τέλος κάθε έτους
| Έτος | Κέρδη | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $4.21B | -44.03% |
| 2025 | $7.52B | -6.27% |
| 2024 | $8.02B | 658.32% |
| 2023 | $1.06B | -96.95% |
| 2022 | $34.73B | 42.85% |
| 2021 | $24.31B | 245.52% |
| 2020 | $7.04B | -38.74% |
| 2019 | $11.49B | -3.37% |
| 2018 | $11.89B | -3.41% |
| 2017 | $12.31B | 47.35% |
| 2016 | $8.35B | -6.85% |
| 2015 | $8.97B | -26.76% |
| 2014 | $12.24B | -22.12% |
| 2013 | $15.72B | 39.80% |
| 2012 | $11.24B | -2.08% |
| 2011 | $11.48B | 23.69% |
| 2010 | $9.28B | -14.27% |
| 2009 | $10.83B | 11.69% |
| 2008 | $9.69B | 4.48% |
| 2007 | $9.28B | -28.78% |
| 2006 | $13.03B | 20.63% |
| 2005 | $10.80B | -22.90% |
| 2004 | $14.01B | 329.27% |
| 2003 | $3.26B | -72.34% |
| 2002 | $11.80B | 14.20% |
| 2001 | $10.33B | 79.11% |
| 2000 | $5.77B | 0.00% |
Κέρδη παρόμοιων εταιρειών ή ανταγωνιστών
| Εταιρεία | Κέρδη | Διαφορά Κερδών | Χώρα |
|---|---|---|---|
| $33.60B | 698.18% |
US
|
|
| $17.74B | 321.41% |
US
|
|
| $8.70B | 106.68% |
US
|
|
| $5.95B | 41.32% |
US
|
|
| $21.39B | 408.16% |
CH
|
